-
Product Insights
Duchenne Muscular Dystrophy – Drugs In Development, 2023
Global Markets Direct’s, ‘Duchenne Muscular Dystrophy - Drugs In Development, 2023’, provides an overview of the Duchenne Muscular Dystrophy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Duchenne Muscular Dystrophy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Retinitis Pigmentosa (Retinitis) – Drugs In Development, 2023
Global Markets Direct’s, ‘Retinitis Pigmentosa (Retinitis) - Drugs In Development, 2023’, provides an overview of the Retinitis Pigmentosa (Retinitis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Retinitis Pigmentosa (Retinitis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Spinocerebellar Ataxia (SCA) – Drugs In Development, 2023
Global Markets Direct’s, ‘Spinocerebellar Ataxia (SCA) - Drugs In Development, 2023’, provides an overview of the Spinocerebellar Ataxia (SCA) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Spinocerebellar Ataxia (SCA), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Usher Syndrome – Drugs In Development, 2023
Global Markets Direct’s, ‘Usher Syndrome - Drugs In Development, 2023’, provides an overview of the Usher Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Usher Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
MRI Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
MRI Systems Pipeline Market Report Overview Magnetic Resonance Imaging (MRI) generates clear and detailed images of internal organs and tissues using radiofrequency and a strong magnetic field. MRI is generally preferred for the diagnosis of brain and other neurological disorders. The 3T, 1.5T and 0.2-1.2T MRI systems have been tracked under this category. The MRI Systems pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report...
-
Product Insights
Remote Patient Monitoring Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Remote Patient Monitoring Pipeline Market Report Overview Remote patient monitoring devices are used to retrieve and transmit data through a wireless system to a monitoring station or a physician’s office for further analysis and interpretation. The Remote Patient Monitoring pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed...
-
Product Insights
Multiparameter Patient Monitoring Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Multiparameter Patient Monitoring Pipeline Market Report Overview Multiparameter patient monitoring includes devices used for continuous monitoring of physiological and vital parameters such as temperature, blood pressure (BP), oxygen saturation in blood (SpO2), respiration rate (RR), and capnography (CO2) in patients continuously. These types of monitors are used in emergency settings, operation theatres (OT), intensive care units (ICU), and physician’s clinics. The multiparameter patient monitoring pipeline market research report provides comprehensive information about the Multiparameter patient monitoring pipeline products with a...
-
Product Insights
Net Present Value Model: Wave Life Sciences Ltd’s WVEN-531
Empower your strategies with our Net Present Value Model: Wave Life Sciences Ltd's WVEN-531 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Net Present Value Model: Wave Life Sciences Ltd’s WVEN-531
Empower your strategies with our Net Present Value Model: Wave Life Sciences Ltd's WVEN-531 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: Wave Life Sciences Ltd’s WVE-004
Empower your strategies with our Net Present Value Model: Wave Life Sciences Ltd's WVE-004 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.